Supreme Court Issues Temporary Ban On Patanjali's 'Misleading' Ads

The Supreme Court has taken action against Patanjali Ayurved and its managing director for circulating misleading advertisements about medicinal remedies.

What Happened: The Supreme Court issued a contempt notice to Patanjali Ayurved and its managing director, Acharya Balakrishna, on Tuesday. The company had previously assured the Court that it would stop making misleading claims about medicinal cures, but it appears to have violated this undertaking.

The Court has also prohibited Patanjali Ayurved from advertising or branding its products as treatments for diseases or disorders specified in the Drugs and Magic Remedies (Objectionable Advertisements) Act 1954. The company has been warned against making any statement that could harm any system of medicine. The case will be revisited in two weeks.

See Also: PVR INOX Revives Mumbai’s Beloved Sangam Cinema With High-End Features

The Bench of Justices Hima Kohli and Ahsanuddin Amanullah were hearing a petition filed by the Indian Medical Association (IMA) to stop the “smear campaign” and negative advertisements against the vaccination drive and modern medicines.

The Court has also asked the Union Government to explain what actions it has taken under the Drugs and Magic Remedies (Objectionable Advertisements) Act 1954 regarding Patanjali’s advertisements.

Read Next: Reliance Jio And Qualcomm Team Up To Launch Sub-$99 5G Smartphone In India Soon


Engineered by Benzinga Neuro, Edited by Utkarsh Roshan


The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.


Market News and Data brought to you by Benzinga APIs

Don't miss a beat on the share market. Get real-time updates on top stock movers and trading ideas on Benzinga India Telegram channel.

Posted In: NewsHealth CareLegalGeneralPatanjali